Sushrut Patil

495 total citations
35 papers, 292 citations indexed

About

Sushrut Patil is a scholar working on Hematology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Sushrut Patil has authored 35 papers receiving a total of 292 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Hematology, 13 papers in Oncology and 9 papers in Pathology and Forensic Medicine. Recurrent topics in Sushrut Patil's work include Hematopoietic Stem Cell Transplantation (13 papers), Acute Myeloid Leukemia Research (10 papers) and Lymphoma Diagnosis and Treatment (9 papers). Sushrut Patil is often cited by papers focused on Hematopoietic Stem Cell Transplantation (13 papers), Acute Myeloid Leukemia Research (10 papers) and Lymphoma Diagnosis and Treatment (9 papers). Sushrut Patil collaborates with scholars based in Australia, United States and New Zealand. Sushrut Patil's co-authors include Andrew Spencer, Mark Tacey, Andrew H. Wei, Danny Liew, Sharon Avery, Michelle Ananda‐Rajah, John Coutsouvelis, C. Orla Morrissey, Anton Y. Peleg and C. O. Morrissey and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Sushrut Patil

30 papers receiving 285 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sushrut Patil Australia	10	98	81	78	68	66	35	292
Costas K. Yannakou Australia	9	63 0.6×	129 1.6×	120 1.5×	44 0.6×	133 2.0×	41	325
Feng‐Ming Tien Taiwan	12	184 1.9×	71 0.9×	51 0.7×	105 1.5×	80 1.2×	27	351
A. Escudero Spain	8	164 1.7×	57 0.7×	45 0.6×	38 0.6×	77 1.2×	13	274
Daniela Vallerini Italy	9	52 0.5×	96 1.2×	53 0.7×	19 0.3×	118 1.8×	15	233
Elisa López‐Fernández Spain	8	78 0.8×	92 1.1×	102 1.3×	57 0.8×	55 0.8×	10	262
Elettra Ortu La Barbera Italy	11	136 1.4×	58 0.7×	48 0.6×	68 1.0×	68 1.0×	30	301
Tomofumi Yano Japan	9	40 0.4×	83 1.0×	88 1.1×	63 0.9×	66 1.0×	25	257
Laëtitia Souchet France	6	52 0.5×	98 1.2×	93 1.2×	22 0.3×	55 0.8×	19	304
Giovanni Rossi Italy	11	145 1.5×	31 0.4×	27 0.3×	78 1.1×	35 0.5×	27	276
J Maertens Belgium	7	65 0.7×	56 0.7×	53 0.7×	20 0.3×	112 1.7×	10	250

Countries citing papers authored by Sushrut Patil

Since Specialization

Citations

This map shows the geographic impact of Sushrut Patil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sushrut Patil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sushrut Patil more than expected).

Fields of papers citing papers by Sushrut Patil

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sushrut Patil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sushrut Patil. The network helps show where Sushrut Patil may publish in the future.

Co-authorship network of co-authors of Sushrut Patil

This figure shows the co-authorship network connecting the top 25 collaborators of Sushrut Patil. A scholar is included among the top collaborators of Sushrut Patil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sushrut Patil. Sushrut Patil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

O’Brien, Maureen M., et al.. (2024). Donor Lymphocyte Infusion (DLI) post allogeneic stem cell transplant (allo-SCT) in Acute Myeloid Leukemia (AML) and High-Grade Myelodysplastic Syndrome (MDS). A longitudinal retrospective study using peripheral blood (PB) CD34+ and CD3+ donor chimerism (DC) monitoring. Leukemia Research. 142. 107504–107504.

Curtis, David J., et al.. (2024). CD34 Chimerism Directed Donor Lymphocyte Infusion With or Without Azacitidine Results in Reduced Relapse and Superior Overall Survival When Full Donor Chimerism is Achieved in Allogeneic Stem Cell Transplant Recipients With Acute Myeloid Leukaemia/Myelodysplastic Syndrome. Clinical Lymphoma Myeloma & Leukemia. 24(11). e852–e860.

Fleming, Shaun, Adam Ivey, Andrew Spencer, et al.. (2023). Peripheral Blood CD34 Donor Chimerism has Greater Clinical Utility Than CD3 for Detecting Relapse after Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia or Myelodysplastic Syndrome. Transplantation and Cellular Therapy. 29(7). 454.e1–454.e8. 3 indexed citations

Cherk, Martin, Thomas W. Barber, Kenneth Yap, et al.. (2022). Noninvasive Assessment of Acute Graft-Versus-Host Disease of the Gastrointestinal Tract After Allogeneic Hemopoietic Stem Cell Transplantation Using¹⁸F-FDG PET. Journal of Nuclear Medicine. 63(12). 1899–1905. 3 indexed citations

Reynolds, Gemma, Karina Kennedy, Wieland Meyer, et al.. (2021). Consensus guidelines for the diagnosis and management of invasive fungal disease due to moulds other than Aspergillus in the haematology/oncology setting, 2021. Internal Medicine Journal. 51(S7). 177–219. 39 indexed citations

Chunilal, Sanjeev, Jake Shortt, George Grigoriadis, et al.. (2020). Venous thromboembolism in primary central nervous system lymphoma during frontline chemoimmunotherapy. Research and Practice in Thrombosis and Haemostasis. 4(6). 997–1003. 10 indexed citations

Patil, Sushrut, Victoria Potter, & Mohamad Mohty. (2020). Review of conditioning regimens for haplo-identical donor transplants using post-transplant cyclophosphamide in recipients of G-CSF mobilised peripheral stem cell. Cancer Treatment Reviews. 89. 102071–102071. 2 indexed citations

Kliman, David, Sushrut Patil, David J. Curtis, et al.. (2020). Important factors in implementation of lineage-specific chimerism analysis for routine use. Bone Marrow Transplantation. 56(4). 946–948. 2 indexed citations

Casan, Joshua, Jake Shortt, Eliza A. Hawkes, et al.. (2019). Cytarabine-based induction immunochemotherapy in the front-line treatment of older patients with mantle cell lymphoma. Scientific Reports. 9(1). 13544–13544. 5 indexed citations

10.

Ffrench, Rosemary, Maya Korem, David J. Curtis, et al.. (2018). Contemporary analysis of functional immune recovery to opportunistic and vaccine‐preventable infections after allogeneic haemopoietic stem cell transplantation. Clinical & Translational Immunology. 7(10). e1040–e1040. 4 indexed citations

11.

Tam, Constantine S., Hang Quach, Andrew J. Nicol, et al.. (2017). BGB-3111 in Combination with Obinutuzumab in Patients with Chronic Lymphocytic Leukemia and Follicular Lymphoma. Blood. 130. 1745–1745. 1 indexed citations

12.

Wong, Eric, Belinda Butcher, Ashish Bajel, et al.. (2017). A Risk-Adapted Protocol of Prophylactic Zoledronic Acid Prevents Bone Mineral Density Loss Post Allograft: Results of the ALLG Bm07 Phase II Prospective Trial. Biology of Blood and Marrow Transplantation. 23(3). S68–S69.

13.

Tan, Peter, Ing Soo Tiong, Shaun Fleming, et al.. (2016). The mTOR inhibitor everolimus in combination with azacitidine in patients with relapsed/refractory acute myeloid leukemia: a phase Ib/II study. Oncotarget. 8(32). 52269–52280. 20 indexed citations

14.

Gilbertson, Michael, Zoe McQuilten, George Grigoriadis, et al.. (2016). Improved Survival of Older Patients with Mantle Cell Lymphoma (MCL) with Front-Line Cytarabine-Based Immunochemotherapy. Blood. 128(22). 2965–2965. 2 indexed citations

15.

Wei, Andrew H., Peter Tan, Shaun Fleming, et al.. (2015). Maintenance lenalidomide in combination with 5‐azacitidine as post‐remission therapy for acute myeloid leukaemia. British Journal of Haematology. 169(2). 199–210. 25 indexed citations

16.

Cherk, Martin, Sushrut Patil, Paul Beech, & Victor Kalff. (2014). Heterogeneous bone marrow uptake on interim 18F-fluorodeoxyglucose positron emission tomography for lymphoma mimicking disease progression: a case report. Journal of Medical Case Reports. 8(1). 362–362. 1 indexed citations

17.

Fong, Chun Yew, George Grigoriadis, John Coutsouvelis, et al.. (2012). Fludarabine, cytarabine, granulocyte-colony stimulating factor and amsacrine: an effective salvage therapy option for acute myeloid leukemia at first relapse. Leukemia & lymphoma. 54(2). 336–341. 12 indexed citations

18.

Wei, Andrew H., Peter Tan, John Catalano, et al.. (2011). Azacitidine in Combination with the mTOR Inhibitor Everolimus in Relapsed and Refractory AML. Blood. 118(21). 2599–2599. 2 indexed citations

19.

Patil, Sushrut, John Coutsouvelis, & Andrew Spencer. (2010). Asparaginase in the management of adult acute lymphoblastic leukaemia: Is it used appropriately?. Cancer Treatment Reviews. 37(3). 202–207. 18 indexed citations

20.

Patil, Sushrut, Andrew Spencer, Anthony P. Schwarer, et al.. (2009). Disease status at autologous stem cell transplantation and the cell of origin phenotype are important predictors of outcome in patients with neurologic (central nervous system) relapse of diffuse large B-cell lymphoma undergoing autologous stem cell transplantation. Leukemia & lymphoma. 50(12). 1964–1968. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact